| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active surveillance vs radical prostatectomy
|
Abrahamsson, Per-Anders
|
|
2007
|
100 |
s2 |
p. 26-28
|
article
|
| 2 |
Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer
|
Bolla, Michel
|
|
2007
|
100 |
s2 |
p. 44-47
|
article
|
| 3 |
Adjuvant treatment to surgery
|
Boccon-Gibod, Laurent
|
|
2007
|
100 |
s2 |
p. 40-43
|
article
|
| 4 |
Chemoprevention of prostate cancer: lessons learned
|
Thompson, Ian M.
|
|
2007
|
100 |
s2 |
p. 15-17
|
article
|
| 5 |
Chemotherapy of premalignant lesions: new insights
|
Ravery, Vincent
|
|
2007
|
100 |
s2 |
p. 18-21
|
article
|
| 6 |
Combination of somatostatin analogues and dexamethasone (antisurvival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis
|
Koutsilieris, Michael
|
|
2007
|
100 |
s2 |
p. 60-62
|
article
|
| 7 |
Controversies regarding screening for prostate cancer
|
Crawford, E. David
|
|
2007
|
100 |
s2 |
p. 5-7
|
article
|
| 8 |
Current prostate cancer: 20 years later
|
Marberger, Michael
|
|
2007
|
100 |
s2 |
p. 11-14
|
article
|
| 9 |
Definition and management of prostate-specific antigen recurrence after local therapy
|
Martínez-Piñeiro, Luis
|
|
2007
|
100 |
s2 |
p. 32-35
|
article
|
| 10 |
Editorial
|
Djavan, Bob
|
|
2007
|
100 |
s2 |
p. 1
|
article
|
| 11 |
European Study of Radical Prostatectomy: time trends in Europe, 1993–2005
|
Djavan, Bob
|
|
2007
|
100 |
s2 |
p. 22-25
|
article
|
| 12 |
Hormone-refractory prostate cancer: what have we learned?
|
Wirth, Manfred P.
|
|
2007
|
100 |
s2 |
p. 56-59
|
article
|
| 13 |
How to preserve potency and continence in localized prostate cancer
|
Breda, Guglielmo
|
|
2007
|
100 |
s2 |
p. 29-31
|
article
|
| 14 |
Is hormone ablation still the right choice for advanced prostate cancer?
|
Fitzpatrick, John M.
|
|
2007
|
100 |
s2 |
p. 36-39
|
article
|
| 15 |
Is the era of prostate-specific antigen over?
|
Djavan, Bob
|
|
2007
|
100 |
s2 |
p. 8-10
|
article
|
| 16 |
Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art
|
Schally, Andrew V.
|
|
2007
|
100 |
s2 |
p. 2-4
|
article
|
| 17 |
Molecular aspects of hormone-independent prostate cancer
|
Schalken, Jack A.
|
|
2007
|
100 |
s2 |
p. 52-55
|
article
|
| 18 |
Multiple intracrine hormonal targets in the prostate: opportunities and challenges
|
Labrie, Fernand
|
|
2007
|
100 |
s2 |
p. 48-51
|
article
|
Journal description